Drug: Avastin (Bevacizumab) to Treat NSCLC

Avastin (Bevacizumab)Avastin for Lung Cancer

Avastin (Bevacizumab) is a cancer medicine that works to stop the growth and spread of cancer cells. It is used to treat certain types of cancers such as brain tumor, ovary, kidney and lung. Avastin when used in combination with carboplatin and palitaxel is approved to treat non-small cell lung cancer (NSCLC) in people who have not received chemotherapy. It is an FDA-approved drug. It is an antiangiogenic agent at the most advanced stage of development in the cancer treatment.


It is given by slow injection into a vein. The recommended dosage is 10mg/kg every 2 weeks in combination with other chemotherapy regimens. The exact dosage depends on the condition of the patient including his medical history, stage of cancer, body weight and more. The duration of this FDA-approved dosage continues until disease progression.

Side Effects

The common side effects of Avastin include headache, high blood pressure, rash and blood clots. It may also cause bleeding and allergic reactions. One should discontinue Avastin in patients with Gastrointestinal perforations. The drug can result in development of a hole in the stomach, small intestine or large intestine. The symptoms may include abdominal pain, nausea, fever and constipation.

Precautions to be Taken

Avastin is not for everyone. One should not take this drug at least one month before or after surgery. If you are pregnant, you should not take Avastin. You should also avoid Avastin when you are planning to become pregnant. Breastfeeding while on Avastin may harm your baby.

You should always consult your doctor before starting intake of any new drug. If you have any questions about your treatment or condition, talk to your doctor.

Share your thoughts on the story in the comments.

The information offered in this blog is for educational purposes only. It is not a substitute for medical advice.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.